AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2021

Type / Class
Debt / NOTE 5.000% 4/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2021 Q4 $0 $0 -$611,000 0
2021 Q3 $519 $611,000 117726.4% 1
2021 Q2 $519 $618,000 119075.14% 1
2021 Q1 $519 $670,000 -$669,864,451 129094.41% 1
2020 Q4 $519,414 $626,000 -$72,445,856 120.52% 1
2020 Q3 $61,188,394 $73,631,000 +$73,027,568 119.5% 7
2020 Q2 $33,000 $30,000 -$52,118,727 90.91% 1
2020 Q1 $53,323,819 $52,121,000 +$653,852 95.01% 7
2019 Q4 $52,655,964 $51,513,000 +$51,513,000 95.01% 7